| 1 |
32696635 | Correlations of inflammatory factors, CCCK-18, MMP-9 and D-Dimer with APACHE II score and prognosis of patients with acute cerebral hemorrhage. | 2020 Jul 20 |
3 |
| 2 |
33157907 | Effects of Xingnaojing on serum high-sensitivity C-reactive protein and neuron-specific enolase in patients with acute cerebral hemorrhage: A protocol of systematic review and meta-analysis. | 2020 Nov 6 |
2 |
| 3 |
30319609 | Acetylcholine Inhibits Monomeric C-Reactive Protein Induced Inflammation, Endothelial Cell Adhesion, and Platelet Aggregation; A Potential Therapeutic? | 2018 |
2 |
| 4 |
26324506 | Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in naïve hypertensive patients. | 2015 Oct |
1 |
| 5 |
24142631 | The impact of high sensitivity C-reactive protein level on coronary artery spasm as assessed by intracoronary acetylcholine provocation test. | 2013 Nov |
4 |
| 6 |
22902499 | The influence of cholinergic agents on histamine release from HMC-1 human mast cell line stimulated with IgG, C-reactive protein and compound 48/80. | 2012 Nov 27 |
1 |
| 7 |
19268941 | Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. | 2009 Sep |
1 |
| 8 |
17991470 | C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the prospective investigation of the Vasculature in Uppsala Seniors (PIVUS) study. | 2008 Jul |
1 |
| 9 |
17662770 | The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery. | 2007 Aug |
2 |
| 10 |
16565249 | Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. | 2006 Apr |
1 |
| 11 |
15877999 | Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. | 2005 May 15 |
1 |
| 12 |
16127895 | [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris]. | 2005 Aug |
2 |
| 13 |
14686876 | Elevated secretory non-pancreatic type II phospholipase A2 serum activity is associated with impaired endothelial vasodilator function in patients with coronary artery disease. | 2004 May |
1 |
| 14 |
15019545 | Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease. | 2004 Feb |
4 |
| 15 |
15201242 | Relation between C reactive protein concentrations and coronary microvascular endothelial function. | 2004 Jul |
3 |
| 16 |
15289371 | Endothelial dysfunction and mild renal insufficiency in essential hypertension. | 2004 Aug 17 |
1 |
| 17 |
15321699 | C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease. | 2004 Aug |
2 |
| 18 |
12631127 | Endothelial dysfunction and inflammation in asymptomatic proteinuria. | 2003 Feb |
1 |
| 19 |
10729391 | Relation of inflammation to vascular function in patients with coronary heart disease. | 2000 Apr |
2 |
| 20 |
10961964 | Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. | 2000 Aug 29 |
1 |